vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Perella Weinberg Partners (PWP). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $219.2M, roughly 1.5× Perella Weinberg Partners). Perella Weinberg Partners runs the higher net margin — 6.3% vs 4.0%, a 2.3% gap on every dollar of revenue. On growth, Guardian Pharmacy Services, Inc. posted the faster year-over-year revenue change (2.2% vs -2.9%).
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
GRDN vs PWP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $336.6M | $219.2M |
| Net Profit | $13.5M | $13.8M |
| Gross Margin | 22.7% | — |
| Operating Margin | 5.3% | 8.5% |
| Net Margin | 4.0% | 6.3% |
| Revenue YoY | 2.2% | -2.9% |
| Net Profit YoY | 46.1% | — |
| EPS (diluted) | $0.21 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | — | ||
| Q4 25 | $397.6M | $219.2M | ||
| Q3 25 | $377.4M | $164.6M | ||
| Q2 25 | $344.3M | $155.3M | ||
| Q1 25 | $329.3M | $211.8M | ||
| Q4 24 | — | $225.7M | ||
| Q3 24 | $314.4M | $278.2M | ||
| Q2 24 | — | $272.0M |
| Q1 26 | $13.5M | — | ||
| Q4 25 | $20.9M | $13.8M | ||
| Q3 25 | $9.8M | $6.0M | ||
| Q2 25 | $9.0M | $2.7M | ||
| Q1 25 | $9.4M | $17.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-122.0M | $16.4M | ||
| Q2 24 | — | $-66.0M |
| Q1 26 | 22.7% | — | ||
| Q4 25 | 21.5% | — | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | — |
| Q1 26 | 5.3% | — | ||
| Q4 25 | 7.7% | 8.5% | ||
| Q3 25 | 4.3% | 5.4% | ||
| Q2 25 | 3.7% | 5.8% | ||
| Q1 25 | 3.9% | 5.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -33.3% | 12.9% | ||
| Q2 24 | — | -30.2% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.3% | 6.3% | ||
| Q3 25 | 2.6% | 3.6% | ||
| Q2 25 | 2.6% | 1.8% | ||
| Q1 25 | 2.9% | 8.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | 5.9% | ||
| Q2 24 | — | -24.3% |
| Q1 26 | $0.21 | — | ||
| Q4 25 | — | $0.11 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $0.04 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $-1.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $255.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $232.4M | $-127.4M |
| Total Assets | $426.9M | $797.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | — | ||
| Q4 25 | $65.6M | $255.9M | ||
| Q3 25 | $36.5M | $185.5M | ||
| Q2 25 | $18.8M | $145.0M | ||
| Q1 25 | $14.0M | $111.2M | ||
| Q4 24 | — | $407.4M | ||
| Q3 24 | $37.2M | $335.1M | ||
| Q2 24 | — | $185.3M |
| Q1 26 | — | — | ||
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | $232.4M | — | ||
| Q4 25 | $217.9M | $-127.4M | ||
| Q3 25 | $195.5M | $-302.4M | ||
| Q2 25 | $179.7M | $-318.4M | ||
| Q1 25 | $163.2M | $-323.1M | ||
| Q4 24 | — | $-421.4M | ||
| Q3 24 | $133.9M | $-360.8M | ||
| Q2 24 | — | $-283.0M |
| Q1 26 | $426.9M | — | ||
| Q4 25 | $412.7M | $797.6M | ||
| Q3 25 | $390.0M | $650.2M | ||
| Q2 25 | $356.3M | $606.7M | ||
| Q1 25 | $334.0M | $570.5M | ||
| Q4 24 | — | $876.8M | ||
| Q3 24 | $348.0M | $810.9M | ||
| Q2 24 | — | $645.5M |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | $34.8M |
| Free Cash FlowOCF − Capex | — | $30.5M |
| FCF MarginFCF / Revenue | — | 13.9% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 0.45× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-34.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | $34.8M | ||
| Q3 25 | $28.2M | $59.2M | ||
| Q2 25 | $19.9M | $56.1M | ||
| Q1 25 | $17.6M | $-176.5M | ||
| Q4 24 | — | $223.4M | ||
| Q3 24 | — | $200.3M | ||
| Q2 24 | — | $90.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $30.5M | ||
| Q3 25 | $24.2M | $57.6M | ||
| Q2 25 | — | $55.3M | ||
| Q1 25 | — | $-177.6M | ||
| Q4 24 | — | $207.0M | ||
| Q3 24 | — | $199.3M | ||
| Q2 24 | — | $83.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.9% | ||
| Q3 25 | 6.4% | 35.0% | ||
| Q2 25 | — | 35.6% | ||
| Q1 25 | — | -83.8% | ||
| Q4 24 | — | 91.7% | ||
| Q3 24 | — | 71.6% | ||
| Q2 24 | — | 30.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | 1.1% | 0.9% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | 2.52× | ||
| Q3 25 | 2.87× | 9.85× | ||
| Q2 25 | 2.21× | 20.50× | ||
| Q1 25 | 1.86× | -10.18× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 12.23× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.